Intelligent Ultrasound Group (LSE:IUG) ROCE % : -28.54% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Intelligent Ultrasound Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Intelligent Ultrasound Group's annualized ROCE % for the quarter that ended in Jun. 2024 was -28.54%.

Intelligent Ultrasound Group ROCE % Historical Data

The historical data trend for Intelligent Ultrasound Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Ultrasound Group ROCE % Chart

Intelligent Ultrasound Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-42.45

-35.48

-35.80

-31.52

-25.75

Intelligent Ultrasound Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-26.32	-41.00	-9.10	-43.88	-28.54

Intelligent Ultrasound Group ROCE % Calculation

Intelligent Ultrasound Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2.994	/	( ( (16.014 - 3.279)	+	(13.79 - 3.271) )	/ 2 )
	=	-2.994	/	( (12.735	+	10.519)	/ 2 )
	=	-2.994	/	11.627
	=	-25.75 %

Intelligent Ultrasound Group's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-2.738	/	( ( (13.79 - 3.271)	+	(20.502 - 11.831) )	/ 2 )
	=	-2.738	/	( ( 10.519	+	8.671 )	/ 2 )
	=	-2.738	/	9.595
	=	-28.54 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Intelligent Ultrasound Group (LSE:IUG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Intelligent Ultrasound Group ROCE % Related Terms

Thank you for viewing the detailed overview of Intelligent Ultrasound Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Ultrasound Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intelligent Ultrasound Group PLC (LSE:IUG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

114-116 St Mary Street, Floor 6A, Hodge House, Cardiff, GBR, CF10 1DY

Website

https://www.intelligentultrasound.com

Intelligent Ultrasound Group PLC is engaged in the development, marketing, and distribution of ultrasound simulation devices for use in the training of medical professionals. Its product categories ScanTrainer; HeartWorks; BodyWorks; and ORSIM Bronchoscopy Simulator. The Company has two reportable segments such as Simulation which involves sales of ultrasound simulation systems and related services, and Clinical AI which is involved in sales of AI-related ultrasound image analysis software products. The company earns the majority of its revenue from the Simulation segment. Geographically, it has a presence in the United Kingdom, North America, and the Rest of the World. It derives the maximum of its revenue from the Rest of the World.

Intelligent Ultrasound Group Headlines

No Headlines